The MATCH Monopoly and What It Actually Means for Health Tech

Key Takeaways

• 9,000 medical graduates unmatched in 2025.
• Resident salaries lag inflation, needing ~26% raise.
• Medicare caps limit residency slots, driving physician shortage.
• Proposed act adds 14,000 GME positions by 2032.
• Antitrust reform could boost resident wages and tech opportunities.

Summary

Congressional scrutiny of the National Resident Matching Program’s (NRMP) antitrust exemption intensified after a May 2025 hearing, highlighting wage suppression and a persistent residency bottleneck. In 2025, 52,498 medical students competed for 43,237 slots, leaving roughly 9,000 unmatched, while average PGY‑1 pay hovered around $68,000, far below inflation. The Resident Physician Shortage Reduction Act proposes 14,000 additional Medicare‑funded residency positions over seven years, but the underlying Medicare cap remains a structural constraint. Repealing or modifying the exemption could allow parallel salary negotiations, potentially raising resident compensation and opening new health‑tech market opportunities.

Pulse Analysis

The National Resident Matching Program, a decades‑old algorithmic system that pairs medical graduates with residency slots, now faces renewed antitrust scrutiny. Critics argue that the NRMP’s centralized process, combined with ACGME accreditation control, suppresses resident wages and limits mobility, leaving about 9,000 new doctors without training positions each year. As resident pay stagnates at roughly $68,000 for first‑year trainees—well below inflation—policy makers are questioning whether the 2004 exemption that shields the match from competition law should be revised.

Beyond the wage debate, the real bottleneck lies in federal funding. Medicare has capped the number of residency positions hospitals can fund since 1997, constraining the pipeline despite a modest 4% increase in available slots in 2025. The Resident Physician Shortage Reduction Act seeks to add 14,000 new slots over seven years, yet even that modest expansion falls short of the AAMC’s projection of an 86,000‑physician deficit by 2036. This structural shortage forces health systems to rely more heavily on mid‑level providers and accelerates the push for alternative care delivery models.

For health‑tech investors, these dynamics translate into tangible opportunities. Expanded GME capacity will demand sophisticated administration platforms for compliance, scheduling, and funding management. If antitrust reforms loosen salary negotiations, resident‑focused fintech and benefits solutions become more viable. Moreover, a tighter physician supply fuels demand for AI‑driven clinical decision support, documentation automation, and virtual‑care tools that amplify existing clinicians’ productivity. Companies that can embed themselves in the evolving residency ecosystem stand to capture significant market share as the industry adapts to both policy shifts and a looming physician shortage.